Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

158.64 +3.83 (+2.47%)
Streaming Delayed Price Updated: 5:36 AM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Switzerland Exercises Increased Option for 7.5 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Switzerland exercises increased option for 7.5 million doses of mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases
InvestorNewsBreaks – A Glimpse into Robinhood’s 100 Most Popular Stocks
From InvestorBrandNetwork
Canada Exercises Increased Option for Total of 40 Million Doses of mRNA Vaccine Candidate Against COVID-19 (mRNA-1273)
Canada exercises increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19 (mRNA-1273) 
From Business Wire News Releases
Thinking about buying stock in Pfizer, Moderna, Oncternal Therapeutics, Fate Therapeutics, or Atara Biotherapeutics?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, ONCT, FATE, and ATRA. 
From PR Newswire
Thinking about trading options or stock in Moderna, Exxon Mobil, American Airlines, Blink Charging, or Ambarella?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, XOM, AAL, BLNK, and AMBA. 
From PR Newswire
Moderna Announces Amendment to Supply Agreement with the Ministry of Health of Israel to Supply Additional Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna announces amendment to supply agreement with the Ministry of Health of Israel to supply additional doses of mRNA vaccine against COVID-19. 
From Business Wire News Releases
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate
Moderna provides updates on the clinical development and production of its COVID-19 vaccine candidate. 
From Business Wire News Releases
Thinking about trading options or stock in Intel Corp, Moderna, General Electric, American Airlines, or Exxon Mobil?
InvestorsObserver issues critical PriceWatch Alerts for INTC, MRNA, GE, AAL, and XOM. 
From PR Newswire
Thinking about buying stock in Titan Pharmaceuticals, Moderna, Moleculin Biotech, Corbus Pharmaceuticals, or Altimmune?
InvestorsObserver issues critical PriceWatch Alerts for TTNP, MRNA, MBRX, CRBP, and ALT. 
From PR Newswire
Thinking about buying stock in Moderna, Aurora Cannabis, China Automotive Systems, GameStop, or Sunesis Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, ACB, CAAS, GME, and SNSS. 
From PR Newswire
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
Moderna announces primary efficacy analysis in Phase 3 COVE study for Its COVID-19 vaccine candidate. 
From Business Wire News Releases
Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna announces amendment to current supply agreement with United Kingdom government for an additional 2 million doses of mRNA-1273. 
From Business Wire News Releases
Moderna to Present at Upcoming Investor Conferences in December 2020
Moderna to present at upcoming investor conferences in December 2020. 
From Business Wire News Releases
Thinking about trading options or stock in Novavax, Tesla, AstraZeneca, Apple, or Moderna?
InvestorsObserver issues critical PriceWatch Alerts for NVAX, TSLA, AZN, AAPL, and MRNA. 
From PR Newswire
Thinking about buying stock in Altimmune, General Electric, Moderna, Delta Air Lines, or Norwegian Cruise Line?
InvestorsObserver issues critical PriceWatch Alerts for ALT, GE, MRNA, DAL, and NCLH. 
From PR Newswire
Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna announces the European Commission’s approval of advance purchase agreement for initial 80 million doses of mRNA vaccine against COVID-19 
From Business Wire News Releases
More Stringent Testing is Needed as Regions Head for More Lockdowns
- FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in HTG Molecular Diagnostics, Moderna, FuelCell Energy, BioNTech, or Blink Charging?
InvestorsObserver issues critical PriceWatch Alerts for HTGM, MRNA, FCEL, BNTX, and BLNK. 
From PR Newswire
Thinking about trading options or stock in JOYY Inc, Moderna, Fiserv, L Brands, or Nikola Corp?
InvestorsObserver issues critical PriceWatch Alerts for YY, MRNA, FISV, LB, and NKLA. 
From PR Newswire
Rising Number of Cases Reinforces the Need for Comprehensive Diagnostics
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Pfizer, Moderna, Micro Focus, Riot Blockchain, or PG&E Corp?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, MFGP, RIOT, and PCG. 
From PR Newswire
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
FinancialNewsMedia.com News Commentary 
From PR Newswire
European Medicines Agency Begins Rolling Review of Moderna’s mRNA Vaccine Candidate Against COVID-19 (mRNA-1273)
European Medicines Agency begins rolling review of Moderna’s mRNA vaccine candidate against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 (mRNA-1273) if Approved for Use
Moderna announces supply agreement with United Kingdom government to supply mRNA vaccine against COVID-19 (mRNA-1273) if approved for use 
From Business Wire News Releases
Thinking about buying stock in Pfizer, Moderna, Inovio Pharmaceuticals, AMC Entertainment, or HighPoint Resources?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, INO, AMC, and HPR. 
From PR Newswire
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study 
From Business Wire News Releases
Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures
Moderna announces longer shelf life for its COVID-19 vaccine candidate at refrigerated temperatures 
From Business Wire News Releases
Swissmedic Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)
Swissmedic begins rolling review of Moderna’s mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Thinking about buying stock in Moderna, ACCO Brands, Top Ships, JD.Com, or Xpeng?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, ACCO, TOPS, JD, and XPEV. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.